Opus Genetics (IRD) Stock Chart & Stock Price History $2.02 +0.03 (+1.25%) As of 09:52 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Opus Genetics Stock Price Performance The Opus Genetics (IRD) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock increased 70.17%. In the past month, the stock has increased 44.64%, reflecting recent market activity. As of the latest close, Opus Genetics traded at $2.00 with a market cap of $119.82 million and volume of 291,100 shares. Receive IRD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Opus Genetics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+3.32%1 Month Performance+44.64%3 Month Performance+80.80%Year-To-Date Performance+70.17% IRD Stock Chart for Thursday, October, 16, 2025 IRD Chart by TradingView Opus Genetics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/15/2025$2.00$2.00$2.04$1.90291,100 shs$119.82 million10/14/2025$2.00$2.00$2.02$1.93635,798 shs$119.82 million10/13/2025$1.96$2.00+2.04%$2.06$1.93709,695 shs$119.82 million10/10/2025$1.99$1.96-1.51%$2.05$1.85590,988 shs$117.42 million10/09/2025$2.05$1.99-2.93%$2.09$1.97634,186 shs$119.22 million10/08/2025$2.03$2.05+0.99%$2.05$1.97344,776 shs$122.82 million10/07/2025$2.02$2.03+0.50%$2.16$1.96570,267 shs$121.61 million10/06/2025$1.88$2.02+7.45%$2.11$1.86863,757 shs$121.02 million10/03/2025$1.80$1.88+4.44%$1.92$1.76344,059 shs$112.63 million10/02/2025$1.80$1.80$1.83$1.75242,886 shs$107.84 million Get the Latest News and Ratings for IRD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Opus Genetics and its competitors with MarketBeat's FREE daily newsletter. 10/01/2025$1.65$1.80+9.09%$1.83$1.62329,516 shs$107.84 million09/30/2025$1.79$1.65-7.82%$1.86$1.50554,854 shs$98.85 million09/29/2025$1.82$1.79-1.65%$1.87$1.74387,359 shs$107.24 million09/26/2025$1.72$1.82+5.81%$1.83$1.69548,259 shs$109.04 million09/25/2025$1.64$1.72+4.88%$1.76$1.56404,955 shs$103.05 million09/24/2025$1.66$1.64-1.20%$1.71$1.60224,325 shs$98.25 million09/23/2025$1.71$1.66-2.92%$1.74$1.63309,848 shs$99.45 million09/22/2025$1.52$1.71+12.50%$1.72$1.52713,526 shs$102.45 million09/19/2025$1.49$1.52+2.01%$1.59$1.42869,386 shs$91.06 million09/18/2025$1.43$1.49+4.20%$1.49$1.41367,021 shs$89.26 million09/17/2025$1.40$1.43+2.14%$1.44$1.38213,321 shs$85.67 million09/16/2025$1.37$1.40+2.19%$1.42$1.35214,294 shs$83.87 million09/15/2025$1.38$1.37-0.72%$1.44$1.35148,671 shs$82.07 million Related Companies Rapt Therapeutics Stock Price Chart Alumis Stock Price Chart PureTech Health Stock Price Chart Monte Rosa Therapeutics Stock Price Chart Korro Bio Stock Price Chart Lexeo Therapeutics Stock Price Chart Solid Biosciences Stock Price Chart Astria Therapeutics Stock Price Chart Upexi Stock Price Chart Evolus Stock Price Chart Receive IRD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Opus Genetics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:IRD) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredOptions Pro Reveals His #1 Retirement Income TradeIf you can be at your computer between 9 a.m. and 10:45 a.m. on most weekdays, I’ll show you a simple trading ...Base Camp Trading | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Opus Genetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Opus Genetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
